Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: Importance of training dose and attenuation by the D3 agonist (±)-7-OH-DPAT

Psychopharmacology

Volumn 136, Issue 1, 1998, Pages 59-69

  Cook, Charles D ^a   Picker, Mitchell J ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

( ) 7 OH DPAT; Butorphanol; Dopamine; Drug discrimination; Opioids; Pigeons

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMANTADINE; AMFONELIC ACID; AMPHETAMINE; BUTORPHANOL; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; MAZINDOL; MORPHINE; NALBUPHINE; NALOXONE; OPIATE ANTAGONIST; QUINPIROLE; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG DISCRIMINATION; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PIGEON; PRIORITY JOURNAL; TRAINING;

ANALGESICS, OPIOID; ANIMALS; BUTORPHANOL; COLUMBIDAE; DISCRIMINATION (PSYCHOLOGY); DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, OPIOID, MU; TETRAHYDRONAPHTHALENES;

EID: 0031933229     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050539     Document Type: Article

References (54)

1. Acquas E, Carboni E, Leone P, Di Chiara G (1989) SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology 99: 151-155
2. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4: 69-79
3. Broadbent J, Gaspard TM, Dworkin SI (1995) Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids. Pharmacol Biochem Behav 51: 379-385
4. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103: 50-55
5. Colpaert FC, Niemegeers CJ, Janssen PA (1976) Fentanyl and apomorphine: asymmetrical generalization of discriminative stimulus properties. Neuropharmacology 15: 541-545
6. Colpaert FC, Niemegeers CJ, Janssen PA (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics derived from stimulus generalization experiments. Pharmacol Biochem Behav 10: 535-546
7. Colpaert FC, Niemegeers CJ, Janssen PA (1980) Factors regulating drug cue sensitivity: the effect of training dose in fentanylsaline discrimination. Neuropharmacology 19: 705-713
8. 3 agonist (±)-7-hydroxy-dipropylaminotetralin [(±)-7-OH-DPAT]. Soc Neurosci Abstr (in press)
9. 2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin. Pharmacol Biochem Behav 35: 351-355
10. De Fonseca FR, Rubio P, Martin-Calderon JL, Caine SB, Koob GF, Navarro M (1995) The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol 274: 47-55
11. Dettmar PW, Cowan A, Walter DS (1981) A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats. Eur J Pharmacol 69: 147-153
12. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244: 1067-1080
13. Dykstra LA, Doty P, Johnson AB, Picker MJ (1992) Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend 30: 227-234
14. Gatch MB, Negus SS, Butelman ER, Mello NK (1995) Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys. J Pharmacol Exp Ther 275: 1346-1354
15. Gauvin DV, Young AM (1989) Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology 98: 212-221
16. Gerak LR, France CP (1996) Discriminative stimulus effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 276: 523-531
17. Honkanen A, Piepponen TP, Ahtee L (1994) Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine. Neurosci Lett 180: 119-122
18. Hughes CE, Habash T, Dykstra LA, Picker MJ (1996) Discriminative-stimulus effects of morphine in combination with alpha-and beta-noradrenergic agonists and antagonists in rats. Pharmacol Biochem Behav 53: 979-986
19. Iyengar S, Kim HS, Wood PL (1987) Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat. Neurosci Lett 77: 226-230
20. Johnson DJ, Glick SD (1993) Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats. Pharmacol Biochem Behav 46: 341-347
21. Kamien JB, Spealman RD (1991) Modulation of the discriminative-stimulus effects of cocaine by buprenorphine. Behav Pharmacol 2: 517-520
22. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199: 649-661
23. Koek W, Slangen JL (1982) The role of fentanyl training dose and of the alternative stimulus condition in drug generalization. Psychopharmacology 76: 149-156
24. Leone P, Di Chiara G (1987) Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur J Pharmacol 135: 251-254
25. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89: 8155-8159
26. Leysen J, Tollenaere JP, Koch MHJ, Laduron P (1977) Differentiation of opiate and neuroleptic receptor binding in rat brain. Eur J Pharmacol 43: 253-267
27. 3 receptors: effects of ions and guanine nucleotides. J Pharmacol Exp Ther 274: 790-797
28. McCarten MD, Lal H (1979) Attenuation of the discriminative stimulus strength of morphine by haloperidol. Neuropharmacology 18: 465-467
29. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW, Drieze J (1995) A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther 274: 1325-1337
30. Misra AL, Pontani RB, Vadlamani NL (1987) Stereospecific potentiation of opiate analgesia by cocaine: predominant role of noradrenaline. Pain 28: 129-138
31. Nielson EB, Randrup K, Anderson PH (1989) Amphetamine discrimination: effects of dopamine receptor agonists. Eur J Pharmacol 160: 253-262
32. Picker MJ, Dykstra LA (1989) Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. J Pharmacol Exp Ther 249: 557-566
33. Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA (1990) Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J Pharmacol Exp Ther 254: 13-22
34. Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA (1996) Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by mu, kappa and delta opioid agonists. J Pharmacol Exp Ther 279: 1130-1141
35. Pitts RC, West JP, Morgan D, Dykstra LA, Picker MJ (1996) Opioids and rate of positively reinforced behavior: differential antagonism by naltrexone. Behav Pharmacol 7: 205-215
36. Pollard H, Llorens C, Schwartz JC, Gros C, Dray F (1978) Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Res 151: 392-398
37. Shannon HE, Holtzman SG (1979) Morphine training dose: a determination of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology 61: 239-244
38. Shippenberg TS, Herz A (1988) Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur J Pharmacol 151: 233-242
39. Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265: 53-59
40. Sierra V, Duttaroy A, Lutfy K, Candido J, Billings B, Zito SW, Yoburn BC (1991) Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci 50: 591-597
41. Simantov R (1993) Chronic morphine alters dopamine transporter density in the rat brain: possible role of the mechanism of drug addiction. Neurosci Lett 163: 121-124
42. Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261: 607-615
43. Spealman RD, Bergman J (1994) Opioid modulation of the discriminative stimulus effects of cocaine: comparison of mu, kappa and delta agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol 5: 21-31
44. 3-receptor agonist (±)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 187: 45-48
45. Tang AH, Franklin SR (1991) The discriminative stimulus effects of diazepam in rats at two training doses. J Pharmacol Exp Ther 258: 926-932
46. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268: 495-502
47. Tokuyama S, Wakabayashi H, Hoskins B, Ho IK (1996) Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats. Pharmacol Biochem Behav 54: 461-468
48. 1 receptors by SCH 23390 antagonizes discriminative stimulus effects of pentazocine. Brain Res 496: 377-379
49. Ukai M, Hiraiwa E, Kameyama T (1991) Pentazocine-like discriminative stimulus effects of morphine are blocked by the dopamine D-1 antagonist SCH 23390, but not by the dopamine D-2 antagonist sulpiride. Brain Res 541: 146-148
50. Wakabayashi H, Tokuyama S, Ho IK (1995) Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol and morphine. Neurochem Res 20: 1179-1185
51. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257: 706-713
52. Wood PL (1983) Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides 4: 595-601
53. Wood PL, McQuade P, Richard JW, Thakur M (1983) Agonist/antagonist analgesics and nigrostiatal dopamine metabolism in the rat: evidence of receptor dualism. Life Sci 33: 759-762
54. Young AM, Masaki MA, Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261: 246-257